Cargando…

Androgen receptor-dependent regulation of metabolism in high grade bladder cancer cells

The observed sex disparity in bladder cancer (BlCa) argues that androgen receptor (AR) signaling has a role in these malignancies. BlCas express full-length AR (FL-AR), constitutively active AR splice variants, including AR-v19, or both, and their depletion limits BlCa viability. However, the mechan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Katleba, Kimberley D., Tsamouri, Maria-Malvina, Jathal, Maitreyee, Baek, Han Bit, Armenta, Rebecca B., Tepper, Clifford G., Cortopassi, Gino, Ghosh, Paramita M., Mudryj, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889754/ https://www.ncbi.nlm.nih.gov/pubmed/36720985 http://dx.doi.org/10.1038/s41598-023-28692-z

Ejemplares similares

Beyond Prostate Cancer: An Androgen Receptor Splice Variant Expression in Multiple Malignancies, Non-Cancer Pathologies, and Development
por: Katleba, Kimberley D., et al.
Publicado: (2023)

Comparative Cancer Cell Signaling in Muscle-Invasive Urothelial Carcinoma of the Bladder in Dogs and Humans
por: Tsamouri, Maria Malvina, et al.
Publicado: (2021)

The Androgen Receptor in Prostate Cancer: Effect of Structure, Ligands and Spliced Variants on Therapy
por: Messner, Elisabeth A., et al.
Publicado: (2020)

Androgen receptor transcriptional activity is required for heregulin-1β–mediated nuclear localization of the HER3/ErbB3 receptor tyrosine kinase
por: Jathal, Maitreyee K., et al.
Publicado: (2023)

Cisplatin-induced increase in heregulin 1 and its attenuation by the monoclonal ErbB3 antibody seribantumab in bladder cancer
por: Steele, Thomas M., et al.
Publicado: (2023)

XPO1 inhibition by selinexor induces potent cytotoxicity against high grade bladder malignancies
por: Baek, Han Bit, et al.
Publicado: (2018)

Untargeted Metabolomics Identify a Panel of Urinary Biomarkers for the Diagnosis of Urothelial Carcinoma of the Bladder, as Compared to Urolithiasis with or without Urinary Tract Infection in Dogs
por: Tsamouri, Maria Malvina, et al.
Publicado: (2022)

Transcriptional-translational conflict: a novel exploitable tumor suppressive mechanism
por: Mudryj, Maria, et al.
Publicado: (2023)

The Androgen Receptor is a negative regulator of eIF4E Phosphorylation at S209: Implications for the use of mTOR inhibitors in advanced prostate cancer
por: D’Abronzo, Leandro S., et al.
Publicado: (2017)

Pesticides and Bladder Cancer: Mechanisms Leading to Anti-Cancer Drug Chemoresistance and New Chemosensitization Strategies
por: Lucchesi, Christopher A., et al.
Publicado: (2023)

Non-circadian aspects of BHLHE40 cellular function in cancer
por: Kiss, Zsofia, et al.
Publicado: (2020)

Dacomitinib, but not lapatinib, suppressed progression in castration-resistant prostate cancer models by preventing HER2 increase
por: Jathal, Maitreyee K., et al.
Publicado: (2019)

Expression of CSF1, AR, and SRD5A2 during Postnatal Development of the Boar Reproductive Tract
por: Katleba, Kimberley, et al.
Publicado: (2022)

Obatoclax, a BH3 Mimetic, Enhances Cisplatin-Induced Apoptosis and Decreases the Clonogenicity of Muscle Invasive Bladder Cancer Cells via Mechanisms That Involve the Inhibition of Pro-Survival Molecules as Well as Cell Cycle Regulators
por: Steele, Thomas M., et al.
Publicado: (2019)

Decreased expression of let-7c is associated with non-response of muscle-invasive bladder cancer patients to neoadjuvant chemotherapy
por: Vinall, Ruth L., et al.
Publicado: (2016)

The Role of Androgens and Androgen Receptor in Human Bladder Cancer
por: Martínez-Rojo, Elizabeth, et al.
Publicado: (2021)

Involvement of the Androgen and Glucocorticoid Receptors in Bladder Cancer
por: McBeth, Lucien, et al.
Publicado: (2015)

Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy
por: Pan, Chong-xian, et al.
Publicado: (2015)

Androgen Receptor Signaling in Bladder Cancer
por: Li, Peng, et al.
Publicado: (2017)

Lymphoblast Oxidative Stress Genes as Potential Biomarkers of Disease Severity and Drug Effect in Friedreich's Ataxia
por: Hayashi, Genki, et al.
Publicado: (2016)

Modeling Truncated AR Expression in a Natural Androgen Responsive Environment and Identification of RHOB as a Direct Transcriptional Target
por: Tsai, Hui-Chi, et al.
Publicado: (2012)

Molecular characterization of low grade and high grade bladder cancer
por: Apollo, Alessandro, et al.
Publicado: (2019)

Use of fibrin glue in periodontal flap surgery
por: Jathal, Bimal, et al.
Publicado: (2008)

Androgen deprivation therapy prevents bladder cancer recurrence
por: Izumi, Koji, et al.
Publicado: (2014)

Androgen deprivation therapy and Gleason grade: unravelling implications on survival
por: Scott, Michael, et al.
Publicado: (2019)

Protective Effects of KH-204 in the Bladder of Androgen-Deprived Rats
por: Bae, Woong Jin, et al.
Publicado: (2015)

Androgen receptor in bladder cancer: A promising therapeutic target
por: Tripathi, Abhishek, et al.
Publicado: (2020)

Alterations in expression of the multidrug resistance-associated protein (MRP) gene in high-grade transitional cell carcinoma of the bladder.
por: Clifford, S. C., et al.
Publicado: (1996)

Androgen receptor signalling confers clonogenic and migratory advantages in urothelial cell carcinoma of the bladder
por: Luna‐Velez, Maria V., et al.
Publicado: (2021)

Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice
por: Johnson, Daniel T., et al.
Publicado: (2016)

Androgen receptor activity modulates responses to cisplatin treatment in bladder cancer
por: Kashiwagi, Eiji, et al.
Publicado: (2016)

ARVib suppresses growth of advanced prostate cancer via inhibition of androgen receptor signaling
por: Liu, Chengfei, et al.
Publicado: (2021)

Genistein Combined Polysaccharide (GCP) Can Inhibit Intracrine Androgen Synthesis in Prostate Cancer Cells
por: Batra, Neelu, et al.
Publicado: (2020)

Expression of androgen receptor in non-muscle-invasive bladder cancer predicts the preventive effect of androgen deprivation therapy on tumor recurrence
por: Izumi, Koji, et al.
Publicado: (2016)

Androgen Receptor-Mediated Nuclear Transport of NRDP1 in Prostate Cancer Cells Is Associated with Worse Patient Outcomes
por: Steele, Thomas, et al.
Publicado: (2021)

Intermittent androgen deprivation therapy: recommendations to improve the management of patients with prostate cancer following the GRADE approach
por: Bonfill, Xavier, et al.
Publicado: (2018)

Deep learning diagnostics for bladder tumor identification and grade prediction using RGB method
por: Yoo, Jeong Woo, et al.
Publicado: (2022)

Increased mdr1 gene transcript levels in high-grade carcinoma of the bladder determined by quantitative PCR-based assay.
por: Clifford, S. C., et al.
Publicado: (1994)

Effects of Androgen and Estrogen Receptor Signaling Pathways on Bladder Cancer Initiation and Progression
por: Godoy, Guilherme, et al.
Publicado: (2016)

Prolonged androgen deprivation leads to downregulation of androgen receptor and prostate-specific membrane antigen in prostate cancer cells
por: LIU, TIANCHENG, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_gaq9kg91a7khks1i50i0vbfm7l